Improving Diversity In Clinical Trials: Strategies For Inclusive And Ethical Research

By Luke Gelinas, PhD, Senior IRB Chair Director

Clinical research strives to generate knowledge to enhance healthcare and combat diseases. In an equitable society, research benefits should be accessible to all social groups, irrespective of race, age, gender, or ethnicity. This necessitates the research community, including sponsors, investigators, and IRBs, to actively address barriers to participation. Achieving diversity in clinical trials becomes crucial, specifically for historically underrepresented groups like women, children, individuals with cognitive impairments, the elderly, and racial/ethnic minorities.

By proactively improving access and inclusion, the research community can foster a more just and comprehensive understanding of health for all. Gain valuable insights into inclusive trial design, community engagement, and cultural competency to enhance diversity and ensure more representative study outcomes when you access the full article.